North America and Europe Immunotherapy Market
完整報告名稱與涵蓋範圍
North America and Europe Immunotherapy Market Dynamics and Forecast till 2036
報告摘要
The North America and Europe Immunotherapy Market Dynamics and Forecast till 2036 report evaluates fundamental market growth drivers, clinical restraints, bioprocessing innovations, and healthcare policy shifts through 2035. Growth is accelerated by breakthrough therapy designations, expanding application into non-oncology autoimmune indications, and personalized medicine advancements.
Conversely, high therapy costs, severe immune-related adverse events (irAEs), and complex biomanufacturing requirements act as market growth restraints. Biopharma companies are developing companion diagnostic assays to identify high-responder patient populations and minimize unnecessary treatments. This dynamics analysis offers vital strategic direction for drug developers and medical directors.
授權報價
| Single User Price | $750 USD |
| Multi User Licence (up to 10 users) | $1,000 USD |
| Enterprisewide Price (Global Site License) | $1,250 USD |
目錄 Table of Contents
TABLE OF CONTENT
1.1 DEFINITION 9
1.2 SCOPE OF THE STUDY 9
1.3 Research Objective 9
1.4 MARKET STRUCTURE 10
2 MARKET DYNAMICS 12
2.1 REGULATORY ENVIRONMENT & COMPLIANCE 12
2.1.1 ANALYSIS OF REGULATORY APPROVAL 12
2.1.2 IMPACT OF UPCOMING REGULATIONS AND STANDARDS 13
2.2 MARKET ENTRY & EXIT BARRIERS 14
2.2.1 CAPITAL INVESTMENT REQUIREMENTS 14
2.2.2 COMPETITIVE INTENSITY AND MARKET SATURATION 15
2.3 PRICING & REIMBURSEMENT DYNAMICS 16
2.3.1 MEDICARE PART D REDESIGN AND INFLATION REDUCTION ACT IMPLEMENTATION 16
2.3.2 MEDICARE PART B REIMBURSEMENT STRUCTURE 16
2.3.3 MEDICAID COVERAGE VARIABILITY 16
2.3.4 PRIVATE PAYER PRIOR AUTHORIZATION BURDEN 17
2.3.5 GERMANY: AMNOG PROCESS AND PRICING GUARDRAILS 17
2.3.6 FRANCE: EARLY ACCESS PROGRAM EXPANSION 17
2.3.7 ITALY: AIFA REFORM AND MANAGED ENTRY AGREEMENTS 18
2.3.8 SPAIN: IPT PROCESS AND REGIONAL VARIABILITY 18
2.3.9 EU JOINT CLINICAL ASSESSMENT IMPLEMENTATION 18
2.4 PRODUCT PIPELINE ANALYSIS 19
2.5 PHYSICIAN ADOPTION PATTERNS 21
2.6 PATIENT DEMOGRAPHIC AND DISEASE BURDEN 23
2.7 PESTLE ANALYSIS 25
2.8 OVERVIEW OF EMERGING BIOLOGIC THERAPIES AND COMPETITIVE IMPACT ON ALLERGY IMMUNOTHERAPY 28
2.8.1 EMERGING BIOLOGIC THERAPIES IN ALLERGY TREATMENT 28
2.8.2 COMPETITIVE IMPACT ON ALLERGY IMMUNOTHERAPY 29
圖表清單 List of Tables & Figures
NA
LIST OF FIGURES
FIGURE 1 NORTH AMERICA AND EUROPE IMMUNOTHERAPY MARKET: STRUCTURE 10
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們